Parenteral Products. By: Howida Kamal, Ph.D

Similar documents
Howida Kamal, Ph.D Ass. Prof. of Pharmaceutics, Cairo University

Pharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration

Division 1 Introduction to Advanced Prehospital Care

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

6. SR, XR, CR, and TR are examples of formulations. A) oral B) modified release C) repeat action D) soft gels

NANO 243/CENG 207 Course Use Only

H1N1 Vaccine Administration Manual for Paramedics

Injection Techniques Principles and Practice. Introduction. Learning Objectives 5/18/2015. Richard E. Castillo, OD, DO

PARENTERAL PREPARATIONS

2. The nurse must know the institution's administration procedures for the client's welfare and the nurse's legal protection.

Routes of drug administration

PHAR 7632 Chapter 7. Table Market and Share of Pharmaceuticals by ROA Data from Viswanathan, 2004

Patient Information Publications Warren Grant Magnuson Clinical Center National Institutes of Health

Chapter 3. Learning Objectives. Learning Objectives 9/11/2012. Drug Administration: Safety and Procedures

PIEDMONT ACCESS TO HEALTH SERVICES, INC.

Fundamentals of nursing Medication Administration

Intramuscular injections

MODULE 2 THE LABORATORY RAT

Table of Contents. Intramuscular Injection Secrets. Page 2 of 9. Nursing School Made Simple Guaranteed 2014 SimpleNursing.com All Rights Reserved.

Medicaments Administering Injections

Chapter 7. Principles of Pharmacology

For External Use Only. Should neither be swallowed. Nor injected

Pediatric Medication Calculations

DRAFT PROPOSAL FOR REVISION OF GENERAL MONOGRAPHS: PARENTERAL PREPARATIONS. (July 2012) Draft for comment

<1151> Pharmaceutical Dosage Forms and <1152> Animal Drugs for Use in Animal Feeds

For the use of only Oncologist or a Cancer Hospital or a laboratory Doxorubicin Hydrochloride Liposome Injection 2 mg/ml KEMODOXA

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester

Part 1 Principles and Routes of Medication Administration

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale

NURSING PRACTICE GUIDELINES

1) The subcutaneous injection is given in the arms, abdomen, or thighs. 1)

Intramuscular Injection Technique

Medication Administration. By: Carolyn McCune RN, BSN, MSN, CRNP

Chapter 64 Administration of Injectable Medications

PRESCRIBING INFORMATION. Dextrose Injection USP. (Concentrated Dextrose for Intravenous Administration) 50% (500 mg/ml) Fluid and Nutrient Replenisher

Appendix E: Overview of Vascular

IV therapy. By: Susan Mberenga, RN, MSN. Copyright 2016, 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

Principals and dosage forms of pharmaceutics

Procedures/Risks:central venous catheter

Pharmacy Instructions for Preparation

Clinical Calculation 5 th Edition

905 UNIFORMITY OF DOSAGE UNITS

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259

Industrial Pharmacy (3) Solutions as a dosage form. DR.Saad.M.YACOUB

SUMMARY AND CONCLUSION

Patient information leaflet. Royal Surrey County Hospital. NHS Foundation Trust. Parenteral Nutrition. Nutrition Support Team (NST)

Produced by La Direction des communications du ministère de la Santé et des Services sociaux

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

SUMMARY OF PRODUCT CHARACTERISTICS. Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin.

IV Fluids Nursing B23 Objectives Serum Osmolality 275 to 295 Isotonic

WHAT WORKS? A comprehensive guide to safer needle and syringe selection for injecting drug users. tools for harm reduction

IV Fluids. Nursing B23. Objectives. Serum Osmolality

Intravenous therapy and medication. ELCT Health Department Quality Assurance 2007

Course Syllabus National College of Midwifery /2017

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ASSESSMENT AND CARE Monitor for the following and remove catheter if there is: redness, pain, swelling, firm tissue, exudates, bleeding or leakage.

Assessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form

PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker

WHAT WORKS? A comprehensive guide to safer needle and syringe selection for injecting drug users. Second edition. Fully revised and updated

Administer Parenteral Drugs

EVE 491/591 Toxicology. Toxicant Entry into the Body 2/19/2018. Absorption and Fate of a Toxicant

Draft Guideline on Pharmaceutical Development of Medicines for Paediatric Use. C. Nopitsch-Mai London 1

Pain Relief Options for Labor. Providing you with quality care, information and support

RECONSTITUTION, DOSING AND ADMINISTRATION

Many people use a combination of the standard 17mm cannula and the shorter 13mm cannula length depending where on their body they are inserting.

Definitions. You & Your New Transplant ` 38

TÁMOP A/1-11/ INJECTION TECHNIQUES

MODULE 2 Substance Administration and Blood Collection in the Laboratory Rat

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

STEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID

NORMOSOL -R MULTIPLE ELECTROLYTES INJECTION TYPE 1, USP For Replacing Acute Losses of Extracellular Fluid Flexible Plastic Container

EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3

Cell Membranes, Epithelial Barriers and Drug Absorption p. 1 Introduction p. 2 The Plasma Membrane p. 2 The phospholipid bilayer p.

Veins that are firm to

T Pharmaceutics-I (Dispensing Pharmacy)

WITH APPLICATIONS TO : ; : GENERAL AND SPECIALTY AREAS

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

CHAPTER 4 Medication Preparation & Supplies

Dynamic hip screw (sliding hip screw)

POLYHEAL MICRO - INSTRUCTIONS FOR USE

CSL Behring LLC Albuminar -25 US Package Insert Albumin (Human) USP, 25% Revised: 01/2008 Page 1

Deep Vein Thrombosis

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Objectives. Objectives 9/11/2012. Chapter 12 Pharmacology. Copyright 2013 by Jones & Bartlett Learning, LLC, an Ascend Learning Company

Enhanced delivery methods for greater efficacy

Routes of drug administration. Syringes, needles. Basic principles of local anaesthesia. Geometry of local anaesthesia.

Development of Nutrient Delivery Systems: Ingredients & Challenges

Chapter 7. National EMS Education Standard Competencies (1 of 5) National EMS Education Standard Competencies (2 of 5) Principles of Pharmacology

Overview of CVADs. Type of device commonly used. Dwell time Flushing requirement Associated complications. lumens

Lecture 5: Principles of Drug Administration Drug Therapy in Special Populations Objectives

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy

Chapter Goal. Learning Objectives 9/11/2012. Chapter 6. Venous Access

NEOSPORIN G.U. Irrigant Sterile (neomycin sulfate polymyxin B sulfate solution for irrigation)

CONTROLLED-RELEASE & SUSTAINED-RELEASE DOSAGE FORMS. Pharmaceutical Manufacturing-4

A step-by-step preparation guide

REVISION OF MONOGRAPH ON TABLETS. Tablets

Transcription:

Parenteral Products By: Howida Kamal, Ph.D

Dosage forms Route of administration Enteral INTO Parenteral ONTO Topical

Dosage forms Physical form Solid Liquid Semi-solid Powder Granules Tablets Capsules Suppository Pessary Inserts Sponges Microparticles Nanoparticles Liposomes Films Solution Suspension Emulsion Microemulsion Nanoemulsion Nanosuspension In-situ gels Cream Ointment Paste Gel

Dosage forms Sterility Sterile Free from all forms of microbial life (vegetative & sporing) Free from pathogens Non-sterile Extent of total bioburden Injections (parentrals) Ophthalmic Products

Sterile Products Parenteral Products Ophthalmic Products "para enteron = to avoid the intestines The 1 st Official injection in PB: morphine, 1867. The second cocaine was added 1898 after sterilization was attempted.

1. Sterility Parenteral Products Parenteral Products must meet a number of special criteria such as: 2. Pyrogen free 3. Free from foreign particles 4. Buffered ph Buffer capacity 5. Osmotic pressure (Isotonic, hypotonic, hypertonic) 6. Packaging Product protection Ease of use

Routes of Parenteral Administration Primary Specialized Intravenous (I.V.) Intramuscular (I.M.) Subcutaneous (s.c.) Made into a vein (introduced directly into the blood stream) Made into the striated muscle fibers that lie beneath the subcutaneous layer Made under the skin, into the subcutaneous tissue

Routes of Parenteral Administration Intravenous (I.V.) Intramuscular (I.M.) Subcutaneous (s.c.)

Intravenous injections Injected or infused directly into a vein.

Intravenous injections Site of injection Peripheral line Central line Peripheral veins Hand veins Arm veins Deep central veins Chest veins Neck veins Leg veins Femoral veins Dorsal foot veins Scalp veins (In small children )

Intravenous injections Method of injection Peripheral line Central line Plastic indwelling catheters (PVC, Teflon or polyethylene) Small volume injections 1.5 in length 22 gauge needle Intravenous infusion 1-2-in. long, beveled 18-22 gauge needle Smaller gauge numbers indicate larger outer diameters

Intravenous injections Method of injection -Thoroughly clean the skin-insertion site using alcohol swab for 30 seconds and then allowed to dry -Prepare the injection aseptically. -Aspirate before injection to ensure that the drug will be administered intravenously.

Intravenous injections Drug form Solution Emulsion (O/W) aqueous hydroalcoholic Volume 1 to >1000 ml Small volume Large volume

Intravenous injections Indications a. To achieve an immediate pharmacologic effect, especially in emergencies, such as arrythmias or seizures. b. To treat serious, life-threatening infections c. To guarantee delivery and distribution when hypotension or shock exists. d. To restore rapidly electrolyte and fluid balance. e. To provide continuous nutrition (hyperalimentation) when patients are unable to be fed by mouth. f. To administer drugs which would be too irritating or caustic to be given by other parenteral routes (due to the rapid dilution in the circulating blood and the general insensitivity of the venous wall to pain).

Intravenous injections Precautions (complications) a. Uncontrolled or excessive administration of drugs or fluids cannot be counteracted. b. Injection of microorganisms, toxins, particulate matter, or air. c. Thrombosis at the site of injection or infusion. d. Extravasation of injections or infusions at the site of administration. e. The occurrence of physical or chemical incompatibilities between agents prior to or at the time of injection.

Intramuscular injections Site of injection Gluteal site Deltoid site Vastus lateralis site Ventrogluteal Dorsogluteal

Intramuscular injections Method of injection -Thoroughly clean the skin-insertion site using alcohol swab for 30 seconds and then allowed to dry -Prepare the injection aseptically.- -insert the needle into the patient skin at a 90 angle until approximately 1cm of the needle is left showing- -Aspirate before injection to ensure that the drug will NOT be administered intravenously.

Intramuscular injections Drug form Most liquid pharmaceutical forms can be given intramusculary Solution Suspension Emulsion Aqueous Oily Aqueous Colloidal Oily O/W W/O

Intramuscular injections Volume 1-5 ml for adults Much smaller volumes are acceptable in children

Intramuscular injections Indications 1. For a reasonably rapid systemic uptake of the drug (15-20 min). (I.M. route is second only to the I.V. route in rapidity of onset of systemic action). 2. For relatively prolonged action (1 to 2h up to several months) this is called de-pot. 3. To inject concentrated and irritant drugs that could damage subcutaneous tissue. (I M injections are less painful when administered correctly because skeletal muscles have fewer pain-sensing nerves 4. To inject relatively larger volumes than S.C. route (larger volumes can be absorbed because of the rapid uptake of the drug into the blood stream via the muscle fiber)

Intramuscular injections Precautions (complications) 1. Avoid entering a blood vessel (especially an artery), which might lead to: Infusion of a toxic agent or a toxic vehicle directly to an organ or tissue. Introducing a particulate matter from a suspension to a blood vessel which lead to clot formation. 2. The accidental striking of or injection into a peripheral nerve may result in a peripheral sensory damage. 3. If a large bolus of drug is injected, local damage or muscle infarction may result, leading to: A sterile abscess Elevation of serum levels of muscle enzymes. This may present confusing diagnostic problems, especially in patients under suspicion of having a myocardial infarction or hepatitis. 4. Septic abscesses may result if m.o. from the skin flora punched in by the needle at the time of injection. 5. The intramuscular route should never be employed in patients with significant heart failure or shock.

Subcutaneous injections Site of injection side of the arm front of the thigh back of the arm. abdomen

Subcutaneous injections Method of injection Beveled, 24 to 25 gauge, 1/4 to 5/8-in. long needle

Subcutaneous injections Method of injection -Thoroughly clean the skin-insertion site using alcohol swab for 30 seconds and then allowed to dry -Prepare the injection aseptically. - insert the needle into the patient skin at a 45 o or 90 angle -Aspirate before injection to ensure that the drug will NOT be administered intravenously. - Press or rub the site for a few seconds.

Subcutaneous injections Drug form Solution Fine particles low viscosity suspensions Volume 0.5-1.5 ml

Subcutaneous injections Indications For drugs which cannot be administered orally because of lack of absorption from or inactivation by the contents of the gastrointestinal tract (insulin, vaccines and narcotics)

Subcutaneous injections Limitations a. Absorption is slower and less predictable than by the intramuscular route.(due to little blood flow to fatty tissue) b. If heart failure, shock, or vascular collapse exists, this route should not be depended upon. c. Medications that are highly acidic, alkaline, or irritating, should not be administered by this route as they cause the production of pain, inflammation and necrosis of tissues. d. Subcutaneous injections are not given if the skin is burned, hardened, inflamed, swollen, or damaged by a previous injection